Michel Langlois

1.3k total citations
41 papers, 1.0k citations indexed

About

Michel Langlois is a scholar working on Organic Chemistry, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Michel Langlois has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 20 papers in Cellular and Molecular Neuroscience and 16 papers in Molecular Biology. Recurrent topics in Michel Langlois's work include Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Circadian rhythm and melatonin (10 papers). Michel Langlois is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neurotransmitter Receptor Influence on Behavior (11 papers) and Circadian rhythm and melatonin (10 papers). Michel Langlois collaborates with scholars based in France, Switzerland and Italy. Michel Langlois's co-authors include Rodolphe Fischmeister, Monique Gastineau, Monique Mathé‐Allainmat, Sames Sicsic, Olivier Blondel, Jean Andrieux, Isabelle Berque‐Bestel, Philippe Delagrange, Jean‐Louis Soulier and Jeanne Mialet‐Perez and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and Journal of Neurochemistry.

In The Last Decade

Michel Langlois

41 papers receiving 1.0k citations

Peers

Countries citing papers authored by Michel Langlois

Since Specialization

Citations

This map shows the geographic impact of Michel Langlois's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Langlois with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Langlois more than expected).

Fields of papers citing papers by Michel Langlois

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Langlois. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Langlois. The network helps show where Michel Langlois may publish in the future.

Co-authorship network of co-authors of Michel Langlois

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Langlois. A scholar is included among the top collaborators of Michel Langlois based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Langlois. Michel Langlois is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis of new N-(arylcyclopropyl)acetamides and N-(arylvinyl)acetamides as conformationally-restricted ligands for melatonin receptors 2012 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), Michel Langlois, Daniel‐Henri Caignard, Pierre Renard, Philippe Delagrange, Monique Mathé‐Allainmat	15
2	5-HT₄Receptor Ligands: Applications and New Prospects 2003 ·Journal of Medicinal Chemistry ·Michel Langlois, Rodolphe Fischmeister	91
3	Isolation of the serotoninergic 5‐HT_4(e) receptor from human heart and comparative analysis of its pharmacological profile in C6‐glial and CHO cell lines 2000 ·British Journal of Pharmacology ·Jeanne Mialet‐Perez, Isabelle Berque‐Bestel, Pierre Eftekhari, Monique Gastineau, (unknown), (unknown), Patrick Donzeau‐Gouge, Johan Hoebeke, Michel Langlois, Sames Sicsic, Rodolphe Fischmeister, Frank Lezoualc’h	56
4	Benzamides derived from 1,2-diaminocyclopropane as novel ligands for human D2 and D3 dopamine receptors 2000 ·Bioorganic & Medicinal Chemistry ·Donglaï Yang, (unknown), Valérie Audinot, (unknown), Michel Langlois	11
5	Exploration of the ligand binding site of the human 5‐HT₄ receptor by site‐directed mutagenesis and molecular modeling 2000 ·British Journal of Pharmacology ·Jeanne Mialet‐Perez, (unknown), Frank Lezoualc’h, Isabelle Berque‐Bestel, Pierre Eftekhari, Johan Hoebeke, Sames Sicsic, Michel Langlois, Rodolphe Fischmeister	44
6	Pharmacological characterization of the human 5‐HT_4(d) receptor splice variant stably expressed in Chinese hamster ovary cells 2000 ·British Journal of Pharmacology ·Jeanne Mialet‐Perez, (unknown), Sames Sicsic, Michel Langlois, Rodolphe Fischmeister, Frank Lezoualc’h	40
7	Screening of Ligand Binding on Melatonin Receptor Using Non-Peptide Combinatorial Libraries 2000 ·Journal of Receptors and Signal Transduction ·Jean A. Boutin, (unknown), (unknown), Jean‐Paul Nicolas, Jean‐Luc Fauchère, Michel Langlois, (unknown), Philippe Delagrange, Emmanuel Canet	5
8	Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors 2000 ·Bioorganic & Medicinal Chemistry ·(unknown), (unknown), Jean‐Paul Nicolas, Jean A. Boutin, Philippe Delagrange, Pierre Renard, Michel Langlois	14
9	Solid-phase synthesis of 2-methoxyaniline derivatives by the traceless silicon linker strategy 1999 ·Tetrahedron Letters ·(unknown), Michel Langlois	11
10	Synthesis of β-Substituted Naphth-1-yl Ethylamido Derivatives as New Melatoninergic agonists 1999 ·Bioorganic & Medicinal Chemistry ·Monique Mathé‐Allainmat, (unknown), (unknown), Jean Andrieux, Michel Langlois	8
11	Cloning, Expression, and Pharmacology of Four Human 5‐Hydroxytryptamine₄ Receptor Isoforms Produced by Alternative Splicing in the Carboxyl Terminus 1998 ·Journal of Neurochemistry ·Olivier Blondel, Monique Gastineau, (unknown), Michel Langlois, Rodolphe Fischmeister	131
12	Synergistic neurochemical and behavioral effects of fluoxetine and 5-HT1A receptor antagonists 1998 ·European Journal of Pharmacology ·Anne‐Cécile Trillat, Isabelle Malagié, Monique Mathé‐Allainmat, (unknown), C. Jacquot, Michel Langlois, Alain M. Gardier	32
13	Molecular and functional characterization of a 5‐HT₄ receptor cloned from human atrium 1997 ·FEBS Letters ·Olivier Blondel, Grégoire Vandecasteele, Monique Gastineau, (unknown), (unknown), Michel Langlois, Rodolphe Fischmeister	78
14	Structure-activity relationships for substrates and inhibitors of pineal 5-hydroxytryptamine-N-acetyltransferase: preliminary studies 1996 ·European Journal of Pharmacology ·(unknown), (unknown), (unknown), Jean Andrieux, (unknown), Monique Mathé‐Allainmat, E. Chanut, Jean‐Hugues Trouvin, Michel Langlois	8
15	Design and Synthesis of New Naphthalenic Derivatives as Ligands for 2-[125I]Iodomelatonin Binding Sites 1995 ·Journal of Medicinal Chemistry ·Michel Langlois, (unknown), (unknown), (unknown), Jean Andrieux, Sames Sicsic, (unknown), Monique Mathé‐Allainmat, Pierre Renard, Philippe Delagrange	45
16	Structural analysis by the comparative molecular field analysis method of the affinity of β-adrenoreceptor blocking agents for 5-HT1A and 5-HT1B receptors 1993 ·European Journal of Pharmacology Molecular Pharmacology ·Michel Langlois, (unknown), (unknown), (unknown)	50
17	Synthèse de nouvelles amidines bicycliques . Dérivés de la pyrimidine, de la quinazoline et de la diazépine‐1,3 1983 ·Journal of Heterocyclic Chemistry ·Michel Langlois, (unknown), (unknown), (unknown), (unknown)	6
18	Synthesis of the metabolites of oxapadol, a new non‐narcotic analgesic agent 1983 ·Journal of Heterocyclic Chemistry ·(unknown), (unknown), Michel Langlois	2
19	Synthése de nouvelles amidines bicycliques. 1. Dérivés de l'imidazole, du triazole‐1,3,4 et du tétrazole 1982 ·Journal of Heterocyclic Chemistry ·Michel Langlois, (unknown), (unknown), (unknown), (unknown)	8
20	Synthesis and antiarrhythmic activity of new benzofuran derivatives 1981 ·Journal of Medicinal Chemistry ·(unknown), P. Dostert, (unknown), Michel Langlois, (unknown), (unknown)	20

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact